. 2020; 48(7): 664-672 | DOI: 10.5543/tkda.2020.90140 | |||
ST segment yükselmeli miyokart enfarktüsü olan hastalarda “no reflow” öngörmede RCHA2DS2-VASc skoru ve CHA2DS2-VASc skorlarının karşılaştırılmasıÇağrı Zorlu, Cemal KöseoğluTokat Devlet Hastanesi, Kardiyoloji Kliniği, TokatAmaç: “No reflow” distal embolizasyon, mikrovasküler oklüzyon, uzamış miyokardiyal iskemi ve hasardan oluşan bir fenomendir. Primer perkütan koroner girişim sonrası hastaların yaklaşık %5 ila %10’u oranında ortaya çıkar.CHA2DS2-VASc skoru günlük uygulamada kolayca uygulanabilir ve bu skorun komponentleri ile no reflow’un risk faktörleri benzerdir. Kronik böbrek hastalığı hiperkoagülopati riskini getirir ve ST segment yükselmeli miyokart enfarktüsünde (STYME) artmış no reflow riski ile ilişkilidir. Böbrek di̇sfonksiyonu olan hastalarda modifiye CHA2DS2-VASc skorlaması geliştirilmiştir. Bu çalışmanın amacı, no-reflow geli̇şen hastalarda CHA2DS2-VASc skorlama sisteminin prognostik önemini araştırmaktır. Comparison of RCHA2DS2-VASc score and CHA2DS2-VASc score prediction of no-reflow phenomenon in patients with ST-segment elevation myocardial infarctionÇağrı Zorlu, Cemal KöseoğluDepartment of Cardiology, Tokat State Hospital, Tokat, TurkeyObjective: No-reflow is a phenomenon that can arise due to factors such as distal embolization, microvascular occlusion, or prolonged myocardial ischemia and damage. It occurs in about 5% to 10% of patients after primary percutaneous coronary intervention. The CHA2DS2-VASc score can be easily calculated in daily practice and the components of this score are similar to common risk factors for no-reflow. Chronic renal disease generates a hypercoagulable state, which is associated with increased risk of no-reflow in cases of ST-segment elevation myocardial infarction (STEMI). A modified CHA2DS2-VASc score has been developed to include patients with renal dysfunction. The aim of this study was to investigate the prognostic significance of this scoring system, the RCHA2DS2-VASc score, in patients with no-reflow. Çağrı Zorlu, Cemal Köseoğlu. Comparison of RCHA2DS2-VASc score and CHA2DS2-VASc score prediction of no-reflow phenomenon in patients with ST-segment elevation myocardial infarction. . 2020; 48(7): 664-672 Sorumlu Yazar: Cemal Köseoğlu, Türkiye |
|